Mammoth Biosciences' Trevor Martin on using ultra-compact CRISPR systems to go after extra-hepatic indications in-vivo
Trevor Martin describes how Mammoth is working on the evolution of CRISPR to help make it more versatile for potential use in broad in-vivo applications.